Portal Hypertension Completed Phase 2 Trials for Serelaxin (DB05794)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02669875Serelaxin To Lower Portal PressureTreatment